Santo Costa, a former president at Quintiles Transnational, has joined the life sciences practice at the Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan law firm.
Costa has more than 35 years of experience in the life sciences industry. He at one time was general counsel for Glaxo, which later became GlaxoSmithKline. Costa also was a member of the board at Quintiles and Glaxo.
The Smith Anderson firm has been involved in more than 50 life science and healthcare transactions worth more than $4 billion.
“Adding Sandy’s significant experience and accomplishments in the life sciences arena to our team greatly will benefit our clients whether they are large multi-national pharmaceutical companies, venture backed biotechnology companies, or private equity investors in the life sciences industry,” said John Jernigan, managing partner at Smith Anderson.